Cardiovascular Explants
Springer International Publishing (Verlag)
978-3-031-85503-0 (ISBN)
This book matches the most appropriate usage of implants commercially available with the indications for the operations based upon solid diagnostics. Topics covered include an in-depth analysis of the SETA-LATECBA stent-graft and the rapid maturation of stent-graft technology. The challenge of the RVOT reconstruction is also analyzed along with the investigation of vascular grafts at reoperation. Textile fabrics and material selection of heart valves is also covered, with a section devoted to how to prioritize material selection.
This is an ideal book for students and surgeons studying medicine and biomedical engineering, industry professionals working in R&D, as well as regulatory agencies, such as the FDA, SFDA, and Bureau of Medical Devices.
Robert Guidoin PhD is professor of surgery (biomaterials) at Université Laval, Québec, QC (Canada). He studied chemistry at the University of Nantes, France, from 1967-1970. After spending a post-doctoral year at the FAU Erlangen-Nürnberg, Germany, he came to Laval University in 1971 to investigate the blood compatibility of medical devices, such as membrane oxygenators and dialyzers. Further to a specific training in bioengineering at Strathclyde University, Glasgow, Scotland, he was appointed assistant professor of surgery (biomaterials) at Laval University in 1976 before becoming a full professor in 1986. He was appointed as a member of the International College of Fellows of Biomaterials Science and Engineering in 1996, and Fellow of the American Institute for Medical and Biological Engineering in 1998. He was a member of the Sciences Council of Canada (1987-1992). He became Honorary Faculty at Chongqing University, China, the Medical University of Varna, Bulgaria, the University of Sichuan, China, and the Donghua University, China, in 1994, 2001, 2010, and 2013, respectively. He became International Honorary Faculty of the Society of Endovascular and Chinese Medical Doctor Association in 2015. He entered the Canadian Who is Who in 1992. He has made important contributions in the field of vascular and endovascular grafts, heart valves, mechanical hearts, membrane oxygenators, auditor ossicles, breast implants and intra-uterine devices. He has trained many students (35 MSc, 21 PhD, 11 post-doc), and 12 visiting professors on sabbatical leave at his research facilities. During the last decade, he has actively participated in the 111 Program of the Chinese Ministry of Education at Donghua University, Shanghai, China. He was the founder and the first scientific director of the Quebec Biomaterials Institute (1992-2000). He has published more than 300 scientific papers, 24 book chapters, 3 books as co-editor, and has presented his research at numerous meetings worldwide. Robert Guidoin is an internationally leading expert in cardiovascular devices, especially those used for percutaneous techniques.
Lu Wang graduated with BSc and MSc in textile engineering from Donghua University, Shanghai, China, and was awarded a Ph.D. in biomedical textile at ENSITM of University of Haute-Alsace, Mulhouse, France. She has been serving as a professor i
Foreword 1.- Foreword 2.- Serving the good of the patient in cardiovascular implantology: The 3Bs concept shall be heralded as the way to go.- Blood conduits for implantation in open surgery: From infancy to maturity.- Peripheral arterial disease: What you need to know.- Accessibility to treatment of all aortic side branches in endovascular aneurysm repair.- The SETA-Latecba stent graft: An Odyssey.- The docking zone in stent-grafts deployed transrenally: Expression of fibrinolytic activators and inhibitors in the internal capsule lying over the aorta.- Early adverse events following the deployment of Cook-Zenith stent-graft in the descending thoracic aorta: Examination of the explanted devices.- The challenge of the RVOT reconstruction: From palliative surgery to therapeutic advances.- The Ross procedure: A detailed analysis of the explanted valve and the polyester reinforcement prosthesis to tentatively explain adverse events.- Investigation of explanted bioprosthetic heart valves: A comprehensive evaluation platform.- Pericardia are still the most select sources to manufacture percutaneous heart valves.- Conclusion: How to select a peripheral vascular device? A clinician s dilemma.- Postface: Spectacular achievements of Donghua University / Université Laval collaboration in education and research.
| Erscheinungsdatum | 16.07.2025 |
|---|---|
| Zusatzinfo | XXXI, 541 p. 453 illus., 344 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
| Medizin / Pharmazie ► Physiotherapie / Ergotherapie ► Orthopädie | |
| Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
| Technik ► Umwelttechnik / Biotechnologie | |
| Schlagworte | Biofunctionality Biodurability Biocompatibility • cardiovascular explant • explant cardiovascular devices • Material percutaneous heart valves • RVOT reconstruction palliative surgery • RVOT reconstruction therapeutic advances • SETA Latecba stent-graft • stent-graft technology explant • Textile fabrics heart valves • vascular grafts reoperation |
| ISBN-10 | 3-031-85503-5 / 3031855035 |
| ISBN-13 | 978-3-031-85503-0 / 9783031855030 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
